E. Arslan Et Al. , "The association of F-18-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alpha v beta 3 receptor levels in patients with breast cancer," NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.3, pp.260-268, 2020
Arslan, E. Et Al. 2020. The association of F-18-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alpha v beta 3 receptor levels in patients with breast cancer. NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.3 , 260-268.
Arslan, E., Aksoy, T., Can Trabulus, F. D., Kelten Talu, C., Yeni, B., & cermik, T. F., (2020). The association of F-18-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alpha v beta 3 receptor levels in patients with breast cancer. NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.3, 260-268.
Arslan, Esra Et Al. "The association of F-18-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alpha v beta 3 receptor levels in patients with breast cancer," NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.3, 260-268, 2020
Arslan, Esra Et Al. "The association of F-18-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alpha v beta 3 receptor levels in patients with breast cancer." NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.3, pp.260-268, 2020
Arslan, E. Et Al. (2020) . "The association of F-18-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alpha v beta 3 receptor levels in patients with breast cancer." NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.3, pp.260-268.
@article{article, author={Esra Arslan Et Al. }, title={The association of F-18-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin alpha v beta 3 receptor levels in patients with breast cancer}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2020, pages={260-268} }